Stock chart
Ticker: GLYC Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2023-09-25 2023-09-22 B Purchase

Rock Edwin

Chief Medical Officer

Officer
30,403 +8.8%
1.38
41,956 USD
30,403 +8.8% 1.38 41,956 USD
2023-09-25 2023-09-21 B Purchase

Rock Edwin

Chief Medical Officer

Officer
35,000 +11.3%
1.38
48,300 USD
35,000 +11.3% 1.38 48,300 USD
2023-05-18 2023-05-17 S Sale

Hahn Brian M.

SVP Finance, CFO

Officer
3,700 -6.5%
1.95
7,215 USD
3,700 -6.5% 1.95 7,215 USD
2023-05-11 2023-05-10 B Purchase

JUNIUS DANIEL M

Non-Executive Director
30,000 +47.4%
1.56
46,800 USD
30,000 +47.4% 1.56 46,800 USD
2023-05-09 2023-05-08 B Purchase

Johnson Bruce S

SVP & Chief Commercial Officer

Officer
13,500 +10.8%
1.57
21,195 USD
13,500 +10.8% 1.57 21,195 USD
2023-02-28 2023-02-24 B Purchase

Invus Public Equities, L.P.

Large shareholder
100,000 +1.2%
1.70
170,000 USD
100,000 +1.2% 1.70 170,000 USD
2023-02-23 2023-02-23 B Purchase

Invus Public Equities, L.P.

Large shareholder
200,000 +2.4%
1.75
350,760 USD
200,000 +2.4% 1.75 350,760 USD
2023-02-23 2023-02-22 B Purchase

Invus Public Equities, L.P.

Large shareholder
150,000 +1.8%
1.79
268,995 USD
150,000 +1.8% 1.79 268,995 USD
2023-02-23 2023-02-21 B Purchase

Invus Public Equities, L.P.

Large shareholder
50,000 +0.6%
1.85
92,500 USD
50,000 +0.6% 1.85 92,500 USD
2023-02-17 2023-02-17 B Purchase

Invus Public Equities, L.P.

Large shareholder
200,000 +2.5%
1.71
341,000 USD
200,000 +2.5% 1.71 341,000 USD
2023-02-17 2023-02-16 B Purchase

Invus Public Equities, L.P.

Large shareholder
315,266 +4.2%
1.68
531,129 USD
315,266 +4.2% 1.68 531,129 USD
2023-02-17 2023-02-15 B Purchase

Invus Public Equities, L.P.

Large shareholder
1,000,000 +15.2%
2.16
2,155,800 USD
1,000,000 +15.2% 2.16 2,155,800 USD
2023-02-13 2023-02-09 B Purchase

Invus Public Equities, L.P.

Large shareholder
11,451 +0.2%
3.24
37,123 USD
11,451 +0.2% 3.24 37,123 USD
2023-01-27 2023-01-26 S Sale

SANDELL SCOTT D

Large shareholder
1,351,092 -37.7%
3.12
4,213,786 USD
1,351,092 -37.7% 3.12 4,213,786 USD
2023-01-27 2023-01-26 S Sale

SANDELL SCOTT D

Large shareholder
1,648,908 -37.7%
3.12
5,142,614 USD
1,648,908 -37.7% 3.12 5,142,614 USD
2023-01-27 2023-01-25 S Sale

SANDELL SCOTT D

Large shareholder
293,645 -7.6%
3.26
958,428 USD
293,645 -7.6% 3.26 958,428 USD
2023-01-27 2023-01-25 S Sale

SANDELL SCOTT D

Large shareholder
358,371 -7.6%
3.26
1,169,687 USD
358,371 -7.6% 3.26 1,169,687 USD
2023-01-06 2023-01-05 S Sale

SANDELL SCOTT D

Large shareholder
32,139 -0.8%
2.76
88,659 USD
32,139 -0.8% 2.76 88,659 USD
2023-01-06 2023-01-05 S Sale

SANDELL SCOTT D

Large shareholder
39,223 -0.8%
2.76
108,201 USD
39,223 -0.8% 2.76 108,201 USD
2023-01-04 2023-01-04 S Sale

SANDELL SCOTT D

Large shareholder
45,930 -1.2%
2.91
133,643 USD
45,930 -1.2% 2.91 133,643 USD
2023-01-04 2023-01-04 S Sale

SANDELL SCOTT D

Large shareholder
56,054 -1.2%
2.91
163,100 USD
56,054 -1.2% 2.91 163,100 USD
2023-01-04 2023-01-03 S Sale

SANDELL SCOTT D

Large shareholder
78,730 -1.9%
2.99
235,411 USD
78,730 -1.9% 2.99 235,411 USD
2023-01-04 2023-01-03 S Sale

SANDELL SCOTT D

Large shareholder
96,084 -1.9%
2.99
287,301 USD
96,084 -1.9% 2.99 287,301 USD
2023-01-04 2022-12-30 S Sale

SANDELL SCOTT D

Large shareholder
54,645 -1.3%
3.02
165,028 USD
54,645 -1.3% 3.02 165,028 USD
2023-01-04 2022-12-30 S Sale

SANDELL SCOTT D

Large shareholder
66,690 -1.3%
3.02
201,404 USD
66,690 -1.3% 3.02 201,404 USD
2022-12-27 2022-12-22 B Purchase

Rock Edwin

Chief Medical Officer

Officer
110,000 +55.0%
2.25
247,500 USD
110,000 +55.0% 2.25 247,500 USD
2022-11-18 2022-11-17 B Purchase

JUNIUS DANIEL M

Non-Executive Director
20,000 +46.2%
1.87
37,400 USD
20,000 +46.2% 1.87 37,400 USD
2022-11-16 2022-11-15 B Purchase

Rock Edwin

Chief Medical Officer

Officer
100,000 +100.0%
1.66
166,000 USD
100,000 +100.0% 1.66 166,000 USD
2022-11-16 2022-11-14 B Purchase

Rock Edwin

Chief Medical Officer

Officer
100,000 +inf%
1.43
143,000 USD
100,000 +inf% 1.43 143,000 USD
2022-11-14 2022-11-11 B Purchase

PEARSON TIMOTHY R

Non-Executive Director
19,400 +369.5%
1.29
25,026 USD
19,400 +369.5% 1.29 25,026 USD
2022-11-14 2022-11-11 B Purchase

Semerjian Harout

Chief Executive Officer

Executive Director
25,000 +inf%
1.29
32,250 USD
25,000 +inf% 1.29 32,250 USD
2022-11-14 2022-11-11 B Purchase

Hahn Brian M.

SVP Finance, CFO

Officer
20,000 +54.3%
1.06
21,200 USD
20,000 +54.3% 1.06 21,200 USD
2022-11-14 2022-11-11 B Purchase

Girard Armand

SVP, Chief Business Officer

Officer
6,500 +28.7%
1.05
6,825 USD
6,500 +28.7% 1.05 6,825 USD
2022-11-14 2022-11-11 B Purchase

Magnani John L.

SVP of Research, CSO

Officer
45,045 +14.0%
1.17
52,703 USD
45,045 +14.0% 1.17 52,703 USD
2022-03-10 2022-03-09 S Sale

Hahn Brian M.

SVP Finance, CFO

Officer
2,917 -7.3%
1.09
3,180 USD
2,917 -7.3% 1.09 3,180 USD
2022-03-10 2022-03-09 S Sale

Magnani John L.

SVP of Research, CSO

Officer
3,227 -1.0%
1.09
3,517 USD
3,227 -1.0% 1.09 3,517 USD
2022-03-10 2022-03-09 S Sale

Girard Armand

SVP, Chief Business Officer

Officer
2,339 -9.4%
1.09
2,550 USD
2,339 -9.4% 1.09 2,550 USD
2021-11-18 2021-11-16 B Purchase

Andrews Patricia S

Non-Executive Director
40,000 +761.9%
2.05
82,000 USD
40,000 +761.9% 2.05 82,000 USD
2020-12-30 2020-12-28 PS Planned sale

King Rachel K.

President, CEO

Executive Director
84,176 -19.1%
3.91
329,128 USD
84,176 -19.1% 3.91 329,128 USD
2020-11-06 2020-11-04 B Purchase

BVF PARTNERS L P/IL

Large shareholder
86,090 +15.8%
2.60
223,834 USD
86,090 +15.8% 2.60 223,834 USD
2020-11-06 2020-11-04 B Purchase

BVF PARTNERS L P/IL

Large shareholder
506,155 +15.8%
2.60
1,316,003 USD
506,155 +15.8% 2.60 1,316,003 USD
2020-11-06 2020-11-04 B Purchase

BVF PARTNERS L P/IL

Large shareholder
674,492 +15.7%
2.60
1,753,679 USD
674,492 +15.7% 2.60 1,753,679 USD
2020-11-03 2020-10-30 B Purchase

BVF PARTNERS L P/IL

Large shareholder
15,472 +2.9%
2.75
42,548 USD
15,472 +2.9% 2.75 42,548 USD
2020-11-03 2020-10-30 B Purchase

BVF PARTNERS L P/IL

Large shareholder
250,755 +8.5%
2.75
689,576 USD
250,755 +8.5% 2.75 689,576 USD
2020-11-03 2020-10-30 B Purchase

BVF PARTNERS L P/IL

Large shareholder
666,385 +18.3%
2.75
1,832,559 USD
666,385 +18.3% 2.75 1,832,559 USD
2020-03-10 2020-03-09 B Purchase

JUNIUS DANIEL M

Non-Executive Director
20,000 +111.1%
3.40
68,000 USD
20,000 +111.1% 3.40 68,000 USD
2019-09-09 2019-09-05 B Purchase

BVF PARTNERS L P/IL

Large shareholder
124,956 +30.9%
3.18
397,610 USD
124,956 +30.9% 3.18 397,610 USD
2019-09-09 2019-09-05 B Purchase

BVF PARTNERS L P/IL

Large shareholder
689,834 +30.4%
3.18
2,195,052 USD
689,834 +30.4% 3.18 2,195,052 USD
2019-09-09 2019-09-05 B Purchase

BVF PARTNERS L P/IL

Large shareholder
853,956 +30.7%
3.18
2,717,288 USD
853,956 +30.7% 3.18 2,717,288 USD
2019-08-15 2019-08-13 B Purchase

JUNIUS DANIEL M

Non-Executive Director
10,000 +125.0%
3.18
31,800 USD
10,000 +125.0% 3.18 31,800 USD
2018-10-18 2018-10-18 S Sale

Magnani John L.

SVP of Research, CSO

Executive Director
3,527 -4.4%
14.02
49,449 USD
3,527 -4.4% 14.02 49,449 USD
2018-10-18 2018-10-17 S Sale

Magnani John L.

SVP of Research, CSO

Executive Director
7,273 -8.4%
14.00
101,822 USD
7,273 -8.4% 14.00 101,822 USD
2018-10-18 2018-10-16 S Sale

Magnani John L.

SVP of Research, CSO

Executive Director
14,200 -14.1%
14.01
198,942 USD
14,200 -14.1% 14.01 198,942 USD
2018-06-12 2018-06-11 S Sale

Hahn Brian M.

CFO

19,345 -100.0%
18.04
348,984 USD
19,345 -100.0% 18.04 348,984 USD
2018-05-11 2018-05-10 S Sale

BARRIS PETER J

Large shareholder
5,533 -0.1%
17.81
98,543 USD
5,533 -0.1% 17.81 98,543 USD
2018-05-11 2018-05-10 S Sale

BARRIS PETER J

Large shareholder
4,006 -0.1%
17.81
71,347 USD
4,006 -0.1% 17.81 71,347 USD
2018-05-11 2018-05-10 S Sale

SANDELL SCOTT D

Large shareholder
5,533 -0.1%
17.81
98,543 USD
5,533 -0.1% 17.81 98,543 USD
2018-05-11 2018-05-10 S Sale

SANDELL SCOTT D

Large shareholder
4,006 -0.1%
17.81
71,347 USD
4,006 -0.1% 17.81 71,347 USD
2018-05-11 2018-05-10 S Sale

BARRETT M JAMES

Non-Executive Director Large shareholder
5,533 -0.1%
17.81
98,543 USD
5,533 -0.1% 17.81 98,543 USD
2018-05-11 2018-05-10 S Sale

BARRETT M JAMES

Non-Executive Director Large shareholder
4,006 -0.1%
17.81
71,347 USD
4,006 -0.1% 17.81 71,347 USD
2018-05-11 2018-05-10 S Sale

NEW ENTERPRISE ASSOCIATES 10 L P

Large shareholder
5,533 -0.1%
17.81
98,543 USD
5,533 -0.1% 17.81 98,543 USD
2018-05-11 2018-05-10 S Sale

NEW ENTERPRISE ASSOCIATES 10 L P

Large shareholder
4,006 -0.1%
17.81
71,347 USD
4,006 -0.1% 17.81 71,347 USD
2017-12-12 2017-12-08 S Sale

Thackray Helen M.

SVP Clinical Development, CMO

2,000 -1.3%
15.01
30,020 USD
2,000 -1.3% 15.01 30,020 USD
2017-09-18 2017-09-18 S Sale

Thackray Helen M.

SVP Clinical Development, CMO

2,000 -1.3%
13.00
26,000 USD
2,000 -1.3% 13.00 26,000 USD
2017-05-30 2017-05-25 S Sale

Thackray Helen M.

SVP Clinical Development, CMO

Officer
2,000 -1.3%
15.57
31,140 USD
2,000 -1.3% 15.57 31,140 USD
2017-05-22 2017-05-19 PS Planned sale

Thackray Helen M.

SVP Clinical Development, CMO

Officer
2,000 -1.3%
12.14
24,280 USD
2,000 -1.3% 12.14 24,280 USD
2016-12-21 2016-12-20 B Purchase

JUNIUS DANIEL M

Non-Executive Director
5,000 +inf%
6.01
30,050 USD
5,000 +inf% 6.01 30,050 USD
2016-10-04 2016-10-03 PS Planned sale

Thackray Helen M.

VP Clinical Development, CMO

Officer
100 -0.1%
7.01
701 USD
100 -0.1% 7.01 701 USD
2016-10-04 2016-10-03 PS Planned sale

Thackray Helen M.

VP Clinical Development, CMO

Officer
3,900 -2.4%
7.00
27,300 USD
3,900 -2.4% 7.00 27,300 USD
2016-07-21 2016-07-20 PS Planned sale

Thackray Helen M.

VP Clinical Development, CMO

Officer
2,000 -1.2%
8.00
16,000 USD
2,000 -1.2% 8.00 16,000 USD
2016-07-06 2016-07-06 PS Planned sale

Thackray Helen M.

VP Clinical Development, CMO

Officer
6,796 -4.0%
6.68
45,397 USD
6,796 -4.0% 6.68 45,397 USD
2016-07-06 2016-07-05 PS Planned sale

Thackray Helen M.

VP Clinical Development, CMO

Officer
10,136 -5.6%
7.01
71,053 USD
10,136 -5.6% 7.01 71,053 USD
2016-07-06 2016-07-01 PS Planned sale

Thackray Helen M.

VP Clinical Development, CMO

Officer
5,068 -2.7%
7.40
37,503 USD
5,068 -2.7% 7.40 37,503 USD
2016-03-07 2016-03-04 B Purchase

Goldberg Mark Alan

Non-Executive Director
10,397 +945.2%
4.77
49,630 USD
10,397 +945.2% 4.77 49,630 USD
2015-11-18 2015-11-16 S Sale

NEW ENTERPRISE ASSOCIATES 10 L P

Large shareholder
452 -0.0%
6.91
3,123 USD
452 -0.0% 6.91 3,123 USD